DB05071InvestigationalSmall molecule
ACE393 is an injectable vaccine designed to combat the bacterium Campylobacter jejuni, one of the greatest causes of bacterial diarrhoeal infections in the developed world.
- Primary indication
- Investigated for use/treatment in diarrhea and infectious and parasitic disease (unspecified).Curator reviewed
- Code names
- ACE393
What you can answer from here — as of April 02, 2025
Which companies are running trials of ACE393, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account